Natco Pharma declares interim dividend of ₹1.50 per share; record date Aug 20, 2026
Natco Pharma declared an interim dividend of ₹1.50 per equity share for FY 2026-27. The record date for this dividend is August 20, 2026, with payment starting August 26, 2026.
Dividend announcements are generally positive for shareholders, but the impact is considered medium as it is an interim dividend and the amount is relatively small per share.
The declaration of an interim dividend is a positive sign for shareholders, indicating the company's profitability and its commitment to returning value to its investors.
Natco Pharma Limited announced that its Board of Directors, in a meeting held on August 14, 2026, declared an interim dividend of ₹1.50 per equity share. This interim dividend is for the financial year 2026-27, with each equity share having a face value of ₹2.
The record date for determining the eligibility of shareholders for this interim dividend has been fixed as Thursday, August 20, 2026. The payment of this interim dividend is scheduled to commence from August 26, 2026.
What to do with a filing like this
Natco Pharma Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Natco Pharma Limited. Read the original for the full detail.